+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity

  • ID: 5357373
  • Report
  • June 2021
  • Region: Asia Pacific
  • 102 pages
  • GMD Research

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Betatech Medical
  • CryoLife Inc.
  • CSL Limited
  • Hemostasis LLC
  • Johnson & Johnson
  • MORE
Asia Pacific biosurgery market will grow by 8.9% annually with a total addressable market cap of $33.2 billion over 2021-2027 owing to the growth in joint reconstruction and spinal fusion, the increasing number of surgeries especially minimally invasive surgeries due to lifestyle disorders and the rise in the overweight & aging population.



Highlighted with 31 tables and 49 figures, this 102-page report “Asia Pacific Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific biosurgery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific biosurgery market in every aspect of the classification from perspectives of Product, Source Type, Application, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
  • Hemostatic Agents
  • Bone-graft Substitutes
  • Synthetic Graft Extender
  • Demineralized Bone Matrix
  • Bone Morphogenetic Proteins
  • Cell-Based Matrices
  • Surgical Sealants and Adhesives
  • Natural Surgical Sealing Agents
  • Synthetic Surgical Sealing Agents
  • Soft-tissue Attachments
  • Natural & Biological Mesh/Patch
  • Synthetic Mesh/Patch
  • Adhesion Barriers
  • Natural Adhesion Barriers
  • Synthetic Adhesion Barriers
  • Staple Line Reinforcement
Based on Source Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
  • Natural/Biological Products
  • Synthetic Products
Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section.
  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Gynecological Surgery
  • Other Applications
Geographically, the following national/local markets are fully investigated:
  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of key national markets by Product, Source Type, and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players (this may not be a complete list and extra companies can be added upon request):
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company (C.R. Bard)
  • Betatech Medical
  • CryoLife Inc.
  • CSL Limited
  • Hemostasis LLC
  • Integra Lifesciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Pfizer, Inc.
  • Sanofi S.A.
  • Stryker Corporation
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Betatech Medical
  • CryoLife Inc.
  • CSL Limited
  • Hemostasis LLC
  • Johnson & Johnson
  • MORE
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis

3 Segmentation of Asia Pacific Market by Product
3.1 Market Overview by Product
3.2 Hemostatic Agents
3.3 Bone-graft Substitutes
3.2.1 Synthetic Graft Extender
3.2.2 Demineralized Bone Matrix
3.2.3 Bone Morphogenetic Proteins
3.2.4 Cell-Based Matrices
3.4 Surgical Sealants and Adhesives
3.4.1 Natural Surgical Sealing Agents
3.4.2 Synthetic Surgical Sealing Agents
3.5 Soft-tissue Attachments
3.5.1 Natural & Biological Mesh/Patch
3.5.2 Synthetic Mesh/Patch
3.6 Adhesion Barriers
3.6.1 Natural Adhesion Barriers
3.6.2 Synthetic Adhesion Barriers
3.7 Staple Line Reinforcement

4 Segmentation of Asia Pacific Market by Source Type
4.1 Market Overview by Source Type
4.2 Natural/Biological Products
4.3 Synthetic Products

5 Segmentation of Asia Pacific Market by Application
5.1 Market Overview by Application
5.2 Orthopedic Surgery
5.3 General Surgery
5.4 Neurological Surgery
5.5 Cardiovascular Surgery
5.6 Gynecological Surgery
5.7 Other Applications

6 Asia-Pacific Market 2020-2027 by Country
6.1 Overview of Asia-Pacific Market
6.2 China
6.3 Japan
6.4 India
6.5 Australia
6.6 South Korea
6.7 Rest of APAC Region

7 Competitive Landscape
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company (C.R. Bard)
  • Betatech Medical
  • CryoLife Inc.
  • CSL Limited
  • Hemostasis LLC
  • Integra Lifesciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Pfizer, Inc.
  • Sanofi S.A.
  • Stryker Corporation
List of Tables
Table 1. Snapshot of Asia Pacific Biosurgery Market in Balanced Perspective, 2020-2027
Table 2. Growth Rate of World GDP, 2020-2022
Table 3. Main Product Trends and Market Opportunities in Asia Pacific Biosurgery Market
Table 4. Asia Pacific Biosurgery Market by Product, 2017-2027, $ mn
Table 5. Asia Pacific Biosurgery Market: Bone-Graft Substitutes by Type, 2017-2027, $ mn
Table 6. Asia Pacific Biosurgery Market: Surgical Sealants and Adhesives by Type, 2017-2027, $ mn
Table 7. Asia Pacific Biosurgery Market: Soft-tissue Attachments by Type, 2017-2027, $ mn
Table 8. Asia Pacific Biosurgery Market: Adhesion Barriers by Type, 2017-2027, $ mn
Table 9. Asia Pacific Biosurgery Market by Source Type, 2017-2027, $ mn
Table 10. Asia Pacific Biosurgery Market by Application, 2017-2027, $ mn
Table 11. APAC Biosurgery Market by Country, 2017-2027, $ mn
Table 12. China Biosurgery Market by Product, 2017-2027, $ mn
Table 13. China Biosurgery Market by Source Type, 2017-2027, $ mn
Table 14. China Biosurgery Market by Application, 2017-2027, $ mn
Table 15. Japan Biosurgery Market by Product, 2017-2027, $ mn
Table 16. Japan Biosurgery Market by Source Type, 2017-2027, $ mn
Table 17. Japan Biosurgery Market by Application, 2017-2027, $ mn
Table 18. India Biosurgery Market by Product, 2017-2027, $ mn
Table 19. India Biosurgery Market by Source Type, 2017-2027, $ mn
Table 20. India Biosurgery Market by Application, 2017-2027, $ mn
Table 21. Australia Biosurgery Market by Product, 2017-2027, $ mn
Table 22. Australia Biosurgery Market by Source Type, 2017-2027, $ mn
Table 23. Australia Biosurgery Market by Application, 2017-2027, $ mn
Table 24. South Korea Biosurgery Market by Product, 2017-2027, $ mn
Table 25. South Korea Biosurgery Market by Source Type, 2017-2027, $ mn
Table 26. South Korea Biosurgery Market by Application, 2017-2027, $ mn
Table 27. Biosurgery Market in Rest of APAC by Country/Region, 2017-2027, $ mn
Table 28. B. Braun Melsungen AG: Company Snapshot
Table 29. B. Braun Melsungen AG: Business Segmentation
Table 30. B. Braun Melsungen AG: Product Portfolio
Table 31. B. Braun Melsungen AG: Revenue, 2017-2019, $ mn

List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027
Figure 4. Asia Pacific Biosurgery Market, 2017-2027, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Biosurgery Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Biosurgery Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Five Forces Analysis of Asia Pacific Biosurgery Market
Figure 11. Breakdown of Asia Pacific Biosurgery Market by Product, 2020-2027, % of Revenue
Figure 12. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Product, Value ($ mn) and Share (%)
Figure 13. Asia Pacific Biosurgery Market: Hemostatic Agents, 2017-2027, $ mn
Figure 14. Asia Pacific Biosurgery Market: Bone-graft Substitutes, 2017-2027, $ mn
Figure 15. Asia Pacific Biosurgery Market: Synthetic Graft Extender, 2017-2027, $ mn
Figure 16. Asia Pacific Biosurgery Market: Demineralized Bone Matrix, 2017-2027, $ mn
Figure 17. Asia Pacific Biosurgery Market: Bone Morphogenetic Proteins, 2017-2027, $ mn
Figure 18. Asia Pacific Biosurgery Market: Cell-Based Matrices, 2017-2027, $ mn
Figure 19. Asia Pacific Biosurgery Market: Surgical Sealants and Adhesives, 2017-2027, $ mn
Figure 20. Asia Pacific Biosurgery Market: Natural Surgical Sealing Agents, 2017-2027, $ mn
Figure 21. Asia Pacific Biosurgery Market: Synthetic Surgical Sealing Agents, 2017-2027, $ mn
Figure 22. Asia Pacific Biosurgery Market: Soft-tissue Attachments, 2017-2027, $ mn
Figure 23. Asia Pacific Biosurgery Market: Natural & Biological Mesh/Patch, 2017-2027, $ mn
Figure 24. Asia Pacific Biosurgery Market: Synthetic Mesh/Patch, 2017-2027, $ mn
Figure 25. Asia Pacific Biosurgery Market: Adhesion Barriers, 2017-2027, $ mn
Figure 26. Asia Pacific Biosurgery Market: Natural Adhesion Barriers, 2017-2027, $ mn
Figure 27. Asia Pacific Biosurgery Market: Synthetic Adhesion Barriers, 2017-2027, $ mn
Figure 28. Asia Pacific Biosurgery Market: Staple Line Reinforcement, 2017-2027, $ mn
Figure 29. Breakdown of Asia Pacific Biosurgery Market by Source Type, 2020-2027, % of Revenue
Figure 30. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Source Type, Value ($ mn) and Share (%)
Figure 31. Asia Pacific Biosurgery Market: Natural/Biological Products, 2017-2027, $ mn
Figure 32. Asia Pacific Biosurgery Market: Synthetic Products, 2017-2027, $ mn
Figure 33. Breakdown of Asia Pacific Biosurgery Market by Application, 2020-2027, % of Revenue
Figure 34. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%)
Figure 35. Asia Pacific Biosurgery Market: Orthopedic Surgery, 2017-2027, $ mn
Figure 36. Asia Pacific Biosurgery Market: General Surgery, 2017-2027, $ mn
Figure 37. Asia Pacific Biosurgery Market: Neurological Surgery, 2017-2027, $ mn
Figure 38. Asia Pacific Biosurgery Market: Cardiovascular Surgery, 2017-2027, $ mn
Figure 39. Asia Pacific Biosurgery Market: Gynecological Surgery, 2017-2027, $ mn
Figure 40. Asia Pacific Biosurgery Market: Other Applications, 2017-2027, $ mn
Figure 41. Breakdown of APAC Biosurgery Market by Country, 2020 and 2027, % of Revenue
Figure 42. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 43. Biosurgery Market in China, 2017-2027, $ mn
Figure 44. Biosurgery Market in Japan, 2017-2027, $ mn
Figure 45. Biosurgery Market in India, 2017-2027, $ mn
Figure 46. Biosurgery Market in Australia, 2017-2027, $ mn
Figure 47. Biosurgery Market in South Korea, 2017-2027, $ mn
Figure 48. Biosurgery Market in Rest of APAC, 2017-2027, $ mn
Figure 49. Growth Stage of Asia Pacific Biosurgery Industry over the Forecast Period
Note: Product cover images may vary from those shown
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company (C.R. Bard)
  • Betatech Medical
  • CryoLife Inc.
  • CSL Limited
  • Hemostasis LLC
  • Integra Lifesciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Pfizer, Inc.
  • Sanofi S.A.
  • Stryker Corporation
  • (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll